EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome

Sunishtha S Yadav, Shilpi Seth, Anwar J Khan, Shailendra S Maurya, Ankur Dhawan, Sidharth Pant, Mohan C Pant, Devendra Parmar

Applied & Translational Genomics · 2014

DOI: 10.1016/j.atg.2013.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied & Translational Genomics, 2014. Verfasst von Sunishtha S Yadav und 7 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, M.G. Marg, Lucknow 226 001, UP, India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0). Gefördert von: SIP-08 of Council of Scientific & Industrial Research (CSIR), N. Delhi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present case-control study involving 750 cases and equal number of healthy controls investigates the association of polymorphism in cytochrome P450 2C9 (CYP2C9) with head and neck squamous cell carcinoma (HNSCC) and response in patients receiving chemotherapy or combination of radio-chemotherapy. The frequency of heterozygous or homozygous genotypes of CYP2C9*2 & CYP2C9*3, which leads to the poor metabolizer (PM) genotype was significantly higher in HNSCC cases when compared to the healthy controls resulting in significantly increased risk in the cases. Tobacco use in the form of tobacco smoking or tobacco chewing was found to increase the risk several fold in cases when compared to the non-tobacco users. Likewise, alcohol intake in cases with variant genotypes of CYP2C9*2 or CYP2C9*3 also significantly increased the HNSCC risk in cases when compared to non-alcohol users. Further, majority of the cases carrying variant alleles of both CYP2C9*2 or CYP2C9*3 were found to respond poorly to the chemotherapy or combination of radio-chemotherapy. The data suggests a significant association of the CYP2C9 polymorphism with HNSCC and treatment outcome.

Schlagwörter

Stichwörter der Autor:innen

CYP2C9HNSCCPMsRadio-chemotherapyTreatment response

Autor:innen und Institutionen

  • Developmental Toxicology Division, CSIR-Indian Institute of Toxicology Research, M.G. Marg, Lucknow 226 001, UP, India.
  • Department of Radiotherapy, King George's Medical University, Lucknow 226 001, India.
  • Dr. R.M.L. Awadh Institute of Medical Sciences, Gomti Nagar, Lucknow, UP, India.

Förderung

  • SIP-08 of Council of Scientific & Industrial Research (CSIR), N. Delhi

Zitieren

APA

Yadav, S. S., Seth, S., Khan, A. J., Maurya, S. S., Dhawan, A., Pant, S., Pant, M. C., & Parmar, D. (2014). Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. Applied & Translational Genomics. https://doi.org/10.1016/j.atg.2013.07.002

Vancouver

Yadav SS, Seth S, Khan AJ, Maurya SS, Dhawan A, Pant S, et al. Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. Applied & Translational Genomics. 2014. doi:10.1016/j.atg.2013.07.002

BibTeX
@article{Yadav2014,
  author = {Yadav, Sunishtha S and Seth, Shilpi and Khan, Anwar J and Maurya, Shailendra S and Dhawan, Ankur and Pant, Sidharth and Pant, Mohan C and Parmar, Devendra},
  title = {Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome},
  journal = {Applied & Translational Genomics},
  year = {2014},
  doi = {10.1016/j.atg.2013.07.002}
}
Kostenlos starten →